Worldwide Recall On Allergan Textured Breast Implants
Executive Summary
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
You may also be interested in...
FDA: 36 Dead From Breast Implant-Associated Lymphoma Since 2019, Hundreds Sickened
The US FDA reports the numbers on women globally who've died or been sickened by two types of breast implant illnesses.
FDA Issues Warning Letters To Breast Implant Makers Allergan And Ideal Implant
The US agency warned Allergan about failing to meet postmarket study requirements and Ideal Implant about Quality System Regulation violations.
Australia Suspends Breast Implants Over Cancer Risk Fears
The Therapeutic Goods Administration has now decided to take regulatory action on breast implants and tissue expanders following its review into the link between these products and a rare type of cancer.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
This content is free with registration!
Start a free trial today!
Register to keep reading and receive our free email digests